Peter J. Arduini is Integra's President and Chief Executive Officer and a director. He joined Integra in November 2010 as President and Chief Operating Officer and was appointed Chief Executive Officer and a director in January 2012. Before joining Integra, Mr. Arduini was Corporate Vice President and President of Medication Delivery, Baxter Healthcare, which he joined in 2005. Mr. Arduini was responsible for a $4.8 billion global division of Baxter. Prior to joining Baxter, Mr. Arduini worked for General Electric Healthcare, where he spent much of his 15 years in a variety of management roles for domestic and global businesses. Prior to joining General Electric Healthcare, he spent four years with Procter and Gamble in sales and marketing. Mr. Arduini serves on the Board of Directors of ADVAMED, the Advanced Medical Technology Association, and the Board of Directors of the National Italian American Foundation. Mr. Arduini received his bachelor's degree in marketing from Susquehanna University and a master's in management from Northwestern University's Kellogg School of Management.
Mark Augusti Corporate Vice President, and President of Orthopedics and Tissue Technologies
Mark Augusti is Integra’s Corporate Vice President, and President of Orthopedics and Tissue Technologies. Mr. Augusti is responsible for the management of the Spine and Extremities divisions which includes spine and extremity implants, orthobiologics, and tissue products. His responsibilities include U.S. commercial leadership, global portfolio management, evaluation of corporate development opportunities and overall strategic direction. He joined Integra in April 2014 as Corporate Vice President and President of Orthopedics and Tissue Technologies, and brings over 25 years of executive management experience in medical technology. Prior to joining Integra, Mr. Augusti served as Chief Executive Officer at Bioventus LLC, from May 2012 to August 2013, and was a member of the company's Board of Directors during the same period. Prior to that Mr. Augusti spent nine years with Smith & Nephew, from April 2003 to April 2012, in a series of leadership roles, including President of Smith & Nephew's Biologic Division, where he was appointed to lead Smith & Nephew's new biologics initiative. He also served as Smith & Nephew's President of the Orthopaedic Trauma & Clinical Therapies Global Business and Senior Vice President and General Manager of the Trauma business. Prior to that, from1987 to 2000, he spent 13 years at GE Medical Systems, where he held various sales, marketing and strategic management roles, both in the U.S. and internationally. Mr. Augusti received his M.B.A. from the UCLA Anderson School of Management, and his B.S. in Computer Science and Economics from Duke University.
Kenneth Burhop, PH.D. is Integra's Corporate Vice President, Chief Scientific Officer. Dr. Burhop is responsible for setting Integra's strategic scientific vision and roadmap, as well as leading the Company's portfolio prioritization and management and the scientific evaluation of corporate development and new product opportunities. He joined Integra in February 2014 as Senior Vice President, Chief Scientific Officer and was appointed Corporate Vice President in March 2014. Prior to joining Integra, Dr. Burhop served as Chief Scientific Officer at Sangart, Inc., from January 2011 to October 2013. Prior to joining Sangart, Inc., he spent 24 years with Baxter Healthcare Corporation, from 1986 through 2010, in a series of leadership roles such as Vice President, R&D, Baxter Pharmaceutical Technologies, and Vice President, Global Scientific Lead for Baxter's Medication Delivery Division, a business with over $4 billion in annual sales. Dr. Burhop received his Ph.D. and M.S. in Veterinary Science from the University of Wisconsin-Madison, and his B.A. in Zoology from University of Wisconsin-Milwaukee.
Glenn G. Coleman is Integra’s Corporate Vice President and Chief Financial Officer. Mr. Coleman is responsible for the Company’s finance department, including accounting and financial reporting, budgeting, internal audit, tax and treasury, as well as investor relations. He joined Integra in May 2014 as Corporate Vice President and Chief Financial Officer, and has 25 years in financial management positions with leading global businesses. Prior to joining the Company, from 2008 to May 2014, Mr. Coleman served as Vice President Finance, Corporate Controller at Curtiss-Wright Corporation, a $2.5 billion global company headquartered in Charlotte, North Carolina that delivers highly-engineered, critical function products and services to the commercial, industrial, defense and energy markets. Prior to joining Curtiss-Wright in 2008, Mr. Coleman worked at Alcatal-Lucent from 1997 to 2007, in various finance executive leadership positions, including Vice President for the Wireless and Wireline Business Groups, Controller for the Americas region, Vice President of Internal Audit and Finance Director of External and Internal Reporting. Mr. Coleman was also instrumental in several significant corporate strategic projects at Alcatel-Lucent, including a multi-billion restructuring program, spin-off of an $8 billion publicly traded entity, and numerous acquisitions. Prior to that, Mr. Coleman began his career at PricewaterhouseCoopers LLP where he was the lead Senior Manager for a top global account. Mr. Coleman received his B.S. degree from Montclair State University and has also been a CPA in New Jersey for more than 20 years.
Robert T. Davis, Jr. is Integra’s Corporate Vice President, President - Neurosurgery. His responsibilities
include leadership of sales, marketing, product development, quality assurance and manufacturing. Mr. Davis joined
Integra in July 2012 as President of the Global Neurosurgery business and was appointed Integra’s Corporate Vice
President in December 2012. He brings more than 25 years of executive management experience in the global
healthcare industry. Prior to joining Integra, Mr. Davis was the General Manager for the Global Anesthesia &
Critical Care business at Baxter Healthcare, from 2009 to 2012, and held various general management positions
at GE Healthcare in the areas of interventional therapeutics, cardiovascular imaging and diagnostic ultrasound,
from 1997 to 2009. Mr. Davis earned his B.S. in Sports Medicine from the University of Delaware, a Master’s degree
in Exercise & Cardiovascular Physiology from Temple University, and an M.B.A. from Drexel University.
Richard D. Gorelick is Integra’s Corporate Vice President, General Counsel, Administration and Secretary.
Mr. Gorelick was appointed Integra’s Corporate Vice President in December 2012. He joined Integra as Vice President
and General Counsel in 2000, and was appointed Senior Vice President and Corporate Secretary in 2006. Mr. Gorelick
also chaired the Human Resources Department from 2008 to 2011. In September 2011, Mr. Gorelick was given the additional
responsibilities of Corporate Communications, Environmental, Health and Safety, Sustainability, Government Relations
and Public Policy, Risk Management, and the Integra Foundation. Prior to joining Integra, he spent four and a half
years at Aventis Behring LLC, a global leader in biologics (plasma proteins) as Associate General Counsel, where his
practice focused on technology licensing, strategic alliances, acquisitions and managing commercial litigation. Prior
to that, Mr. Gorelick worked in the Business and Finance Section of Morgan, Lewis & Bockius LLP, in Philadelphia,
where his practice concentrated on transactions, corporate reorganizations, creditors' rights and secured transactions.
Mr. Gorelick is a graduate of Princeton University and the University of California at Berkeley Law School.
Corporate Vice President, President - Global Spine and Orthobiologics, and Head of Strategic Development
Brian Larkin is Integra’s Corporate Vice President, President - Global Spine and Orthobiologics, and Head of
Strategic Development. His responsibilities include executive oversight and leadership of Integra’s worldwide
Spine and Orthobiologics businesses, in addition to executive oversight of several of Integra’s corporate functions,
including corporate marketing and strategic planning. Mr. Larkin was appointed Integra’s Corporate Vice President in
December 2012. He joined Integra in January 2000 as a Regional Sales Manager. He was promoted to National Sales
Manager in 2003, Vice President, North American Sales in 2005, and President of Integra’s Neurosurgery business in 2007.
In 2010, he was appointed President, Global Spine & Orthobiologics, and Head of Strategic Development. Mr. Larkin has
over 20 years of sales, marketing, and executive management experience in the medical technology industry. Prior to joining
Integra, he was the National Sales Manager for Connell Neurosurgical. Mr. Larkin received a B.S. degree in Chemistry
from the University of Richmond, and completed the Advanced Management Program at Harvard Business School.
Debbie Leonetti is Integra's Corporate Vice President, President - Instruments. Her responsibilities include sales,
marketing and product development for Integra's acute and alternate site instrument businesses. She joined Integra in 1997
as Director of Marketing, was promoted to Vice President of Marketing in April 1999, Senior Vice President of Global Marketing
in May 2004, Chief Marketing Officer in September 2007, President of Latin America, Asia Pacific and Canada (LAPAC) in 2008,
and President of Integra Surgical in 2009. In 2010, Ms. Leonetti was appointed President of Integra's Instrument business and LAPAC.
Ms. Leonetti was appointed President, International, in 2011, Corporate Vice President in December 2012, and President - Instruments
in November 2013. From 1989 through 1997, Ms. Leonetti worked for Cabot Medical, which was later acquired by Circon Corporation, and
held positions in sales, sales training, and marketing. Prior to her experience at Cabot-Circon, Ms. Leonetti completed fifteen years
of clinical practice as a registered nurse at St. Christopher's Hospital for Children in Philadelphia. Ms. Leonetti received her Nursing
degree from St. Joseph's Hospital School of Nursing and La Salle University.
Corporate Vice President, Global Operations and Supply Chain
John Mooradian is Integra’s Corporate Vice President, Global Operations and Supply Chain. His responsibilities include global
manufacturing and supply chain. Mr. Mooradian was appointed Integra’s Corporate Vice President in December 2012. He joined Integra
in September 2012 as Senior Vice President, Global Operations and Supply Chain. Before coming to Integra, Mr. Mooradian spent 24 years
at Abbott Laboratories in a series of leadership roles, including managing the Hematology and Point of Care businesses and, more recently,
worldwide operations at Abbott Diagnostics Division, a $4 billion business with over 11,000 employees. Prior to Abbott, Mr. Mooradian
held several positions at General Motors. Mr. Mooradian received a B.B.A. degree in Management from the University of Texas, Arlington.
Judith E. O’Grady is Integra’s Corporate Vice President, Global Regulatory Affairs, and Corporate Compliance Officer.
She was appointed Integra’s Corporate Vice President in December 2012. Prior to that, Ms. O’Grady was Senior Vice President
of Regulatory Affairs, and Corporate Compliance Officer, from September 2012 to December 2012, and Senior Vice President,
Regulatory Affairs, Quality Assurance, and Corporate Compliance Officer, from 2007 to September 2012. Previously, she was Vice
President of Regulatory Affairs, Quality Assurance and Clinical Affairs. Ms. O’Grady has worked in the areas of medical technology
and collagen technology for over 25 years. Prior to joining Integra, Ms. O’Grady worked for Colla-Tec, Inc., a Marion Merrell
Dow Company. During her career she has held positions with Surgikos, a Johnson & Johnson Company, and was on the faculty of
Boston University College of Nursing and Medical School. Ms. O’Grady led the team that obtained the approval of the Food and
Drug Administration ("FDA") for INTEGRA® Dermal Regeneration Template, the first regenerative product approved by the FDA,
and has led teams responsible for approvals of the Company’s other regenerative product lines as well as more than 600 FDA
and international submissions. Ms. O’Grady received a B.S. degree from Marquette University and M.S.N. in Nursing from Boston
Corporate Vice President, President - International
Dan Reuvers is Integra's Corporate Vice President, President - International. His responsibilities include executive oversight
and leadership of all of Integra's international businesses, including Europe, Middle East, Africa, Latin America, Asia Pacific and Canada.
He joined Integra in 2008 as Vice President of Marketing and Product Development for Integra's surgical business and was promoted to
President of the acute surgical business in June 2010. He was appointed President, Instruments in 2011, Corporate Vice President in
December 2012, and President - International in November 2013. Mr. Reuvers was President of Omni-Tract Surgical from September 2005
until December 2008, when the company was acquired by Integra. Mr. Reuvers has over 25 years of experience in the medical technology field,
including holding various executive level positions in sales, marketing and general management. He serves on the board of directors
of Respirtech, Inc.
Corporate Vice President, Strategic Initiatives and Operational Excellence, and Chief Human Resources Officer
Padma Thiruvengadam is Integra’s Corporate Vice President, Chief Human Resources Officer.
She is responsible for providing leadership in developing and executing human resources strategy in support of
the overall business plan and strategic direction of the organization. She is also responsible for Integra’s
strategic initiatives and program management. Ms. Thiruvengadam was appointed Integra’s Corporate Vice President
in December 2012. Previously, from September 2011 to December 2012, Ms. Thiruvengadam served as Integra’s Chief
Human Resources Officer. Prior to joining Integra, Ms. Thiruvengadam held several leadership positions at Pfizer, Inc., from 2008 to 2011,
including Vice President, Global Human Resources for Oncology. She led the Wyeth integration globally for oncology
and also served as Vice President, Oncology Asia-Pacific/Canada Operations. Prior to joining Pfizer,
Ms. Thiruvengadam served as a Senior Vice President, Human Resources Executive at Bank of America, from 2005 to 2007,
and as Executive Vice President, Human Resource, at Loral Skynet – Loral Space and Communications, from 2001 to 2004.
Ms. Thiruvengadam completed her Master's program from Madras University and her Bachelor’s from Osmania University.
Joseph Vinhais is Integra’s Corporate Vice President, Global Quality Assurance. His responsibilities include
strategic direction for corporate compliance and quality systems. Mr. Vinhais joined Integra in September 2012
as Senior Vice President, Global Quality Assurance, and was appointed Corporate Vice President in December 2012.
Mr. Vinhais has over 20 years of global quality experience in quality assurance, regulatory affairs, compliance,
and operations execution. Prior to joining Integra, Mr. Vinhais was head of Quality Assurance, Regulatory Affairs,
and Sustainability at Philips Healthcare Imaging Systems, from 2009 to September 2012, where he was responsible
for quality assurance and regulatory affairs for the Computed Tomography and Nuclear Medicine business. Prior to
Philips, Mr. Vinhais was General Manager of Quality Assurance & Regulatory Affairs at General Electric Healthcare,
from 2007 to 2009. Mr. Vinhais received a B.S. in Information Sciences and Systems from Central Connecticut State
University, a certificate in Medical Device Management from Worcester Polytechnic Institute, and a certificate in
Regulatory Affairs and Compliance from Northeastern University.